Recently proposed data on the ibuprofen API market analysis demonstrates that demand for ibuprofen APIs is valued at around USD 665 million in 2024 and is on its way to register a CAGR of 2.5% to reach USD 851 million by 2034. The evolving landscape in emerging economies propels the demand boost in the API sector, shaping the pharmaceutical metamorphosis.
Attributes | Details |
---|---|
Market Value for 2024 | USD 665 million |
Market Value for 2034 | USD 851 million |
Market Forecast CAGR for 2024 to 2034 | 2.5% |
Demand is presumed to limit the market growth. The historical CAGR of 3.0% was recorded for the market and a 2.5% CAGR is calculated through 2034.
Attributes | Details |
---|---|
Market Historical CAGR for 2019 to 2023 | 3.0% |
The synthesis of ibuprofen APIs has environmental drawbacks due to revised production guidelines, affecting manufacturers' costs and raw material sourcing. This has led to a downturn in the market, as the drug requires high production value.
Key aspects to influence the demand through 2034 include:
Market players need to be prudent and flexible over the anticipated period, as these challenging attributes position the industry for success in the subsequent decade.
Female Patients Creates a Huge Demand
The Pharmaceutical and Biochemical Industry Rife Ibuprofen Depletion
Demand for Arthritis Medication Rumbles the Growth Rate
Attributes | Details |
---|---|
Top End User | Contract Manufacturing Organization |
Market share in 2024 | 55.30% |
Demand from contract manufacturing organizations (CMOs) is significant, acquiring a market share of 55.6% in 2024. The following aspects contribute to the development of demand from contract manufacturing organizations:
According to derived data, demand from European countries to augment the sales growth in the forthcoming decade. The industry in France and Germany is developing steeply. The ibuprofen drug substance industry in Canada to register the subordinate CAGR compared to European competitors. Demand in Italy and Spain to remain moderate throughout.
Countries | CAGR from 2024 to 2034 |
---|---|
Spain | 3.7% |
Germany | 2.7% |
Italy | 3.3% |
Canada | 2.0% |
France | 3.0% |
Through 2034, the industry in Spain is anticipated to register a 3.7% CAGR, owing to the development of prominent and emerging pharmaceutical and biopharma organizations.
Demand is projected to report a CAGR of 2.7% in Germany through 2034, due to the rising prevalence of chronic diseases such as arthritis and osteoporosis.
Demand in Italy is anticipated to showcase a CAGR of 3.3% between 2024 and 2034 as geriatric patients grow nationwide.
Demand in France is projected to report a CAGR of 3.0% from 2024 to 2034, as women desire demand for ibuprofen API to ease menstruation pain.
Sales is developing rapidly in Canada, witnessing a CAGR of 2.0% through 2034, owing to regular climate change in Canada.
Ibuprofen pharmaceutical ingredient suppliers are merging with CMOs to enhance raw material supply and streamline manufacturing processes, resulting in cost savings and improved time efficiency.
The pharmaceutical API sector is experiencing a surge in mergers and acquisitions, driven by companies seeking therapeutic, pipeline, and global expansion goals. These strategies are gaining popularity due to their significant benefits.
Pooling resources allows companies to create economies of scale, reduce costs, and increase efficiency, especially in product development. Mergers and acquisitions extend market share and help reach new customers for long-term growth.
Mergers and acquisitions are a key growth strategy in the industry, enabling companies to maintain competitiveness, expand globally, and enhance their raw material supply.
Recent Developments in the Ibuprofen API Market
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Prescription Based, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 4: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 5: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by Prescription Based, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 8: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 10: Latin America Market Value (US$ Million) Forecast by Prescription Based, 2019 to 2034
Table 11: Latin America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Western Europe Market Value (US$ Million) Forecast by Prescription Based, 2019 to 2034
Table 15: Western Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 16: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 18: Eastern Europe Market Value (US$ Million) Forecast by Prescription Based, 2019 to 2034
Table 19: Eastern Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 20: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Prescription Based, 2019 to 2034
Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: East Asia Market Value (US$ Million) Forecast by Prescription Based, 2019 to 2034
Table 27: East Asia Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 28: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Prescription Based, 2019 to 2034
Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Prescription Based, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Application, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by End User, 2024 to 2034
Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 8: Global Market Value (US$ Million) Analysis by Prescription Based, 2019 to 2034
Figure 9: Global Market Value Share (%) and BPS Analysis by Prescription Based, 2024 to 2034
Figure 10: Global Market Y-o-Y Growth (%) Projections by Prescription Based, 2024 to 2034
Figure 11: Global Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 14: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 17: Global Market Attractiveness by Prescription Based, 2024 to 2034
Figure 18: Global Market Attractiveness by Application, 2024 to 2034
Figure 19: Global Market Attractiveness by End User, 2024 to 2034
Figure 20: Global Market Attractiveness by Region, 2024 to 2034
Figure 21: North America Market Value (US$ Million) by Prescription Based, 2024 to 2034
Figure 22: North America Market Value (US$ Million) by Application, 2024 to 2034
Figure 23: North America Market Value (US$ Million) by End User, 2024 to 2034
Figure 24: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 28: North America Market Value (US$ Million) Analysis by Prescription Based, 2019 to 2034
Figure 29: North America Market Value Share (%) and BPS Analysis by Prescription Based, 2024 to 2034
Figure 30: North America Market Y-o-Y Growth (%) Projections by Prescription Based, 2024 to 2034
Figure 31: North America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 34: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 37: North America Market Attractiveness by Prescription Based, 2024 to 2034
Figure 38: North America Market Attractiveness by Application, 2024 to 2034
Figure 39: North America Market Attractiveness by End User, 2024 to 2034
Figure 40: North America Market Attractiveness by Country, 2024 to 2034
Figure 41: Latin America Market Value (US$ Million) by Prescription Based, 2024 to 2034
Figure 42: Latin America Market Value (US$ Million) by Application, 2024 to 2034
Figure 43: Latin America Market Value (US$ Million) by End User, 2024 to 2034
Figure 44: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 48: Latin America Market Value (US$ Million) Analysis by Prescription Based, 2019 to 2034
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Prescription Based, 2024 to 2034
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Prescription Based, 2024 to 2034
Figure 51: Latin America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 57: Latin America Market Attractiveness by Prescription Based, 2024 to 2034
Figure 58: Latin America Market Attractiveness by Application, 2024 to 2034
Figure 59: Latin America Market Attractiveness by End User, 2024 to 2034
Figure 60: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 61: Western Europe Market Value (US$ Million) by Prescription Based, 2024 to 2034
Figure 62: Western Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 63: Western Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 64: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 68: Western Europe Market Value (US$ Million) Analysis by Prescription Based, 2019 to 2034
Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Prescription Based, 2024 to 2034
Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Prescription Based, 2024 to 2034
Figure 71: Western Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 74: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 77: Western Europe Market Attractiveness by Prescription Based, 2024 to 2034
Figure 78: Western Europe Market Attractiveness by Application, 2024 to 2034
Figure 79: Western Europe Market Attractiveness by End User, 2024 to 2034
Figure 80: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 81: Eastern Europe Market Value (US$ Million) by Prescription Based, 2024 to 2034
Figure 82: Eastern Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 83: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034
Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Prescription Based, 2019 to 2034
Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Prescription Based, 2024 to 2034
Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Prescription Based, 2024 to 2034
Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 97: Eastern Europe Market Attractiveness by Prescription Based, 2024 to 2034
Figure 98: Eastern Europe Market Attractiveness by Application, 2024 to 2034
Figure 99: Eastern Europe Market Attractiveness by End User, 2024 to 2034
Figure 100: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 101: South Asia and Pacific Market Value (US$ Million) by Prescription Based, 2024 to 2034
Figure 102: South Asia and Pacific Market Value (US$ Million) by Application, 2024 to 2034
Figure 103: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034
Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Prescription Based, 2019 to 2034
Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Prescription Based, 2024 to 2034
Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Prescription Based, 2024 to 2034
Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 117: South Asia and Pacific Market Attractiveness by Prescription Based, 2024 to 2034
Figure 118: South Asia and Pacific Market Attractiveness by Application, 2024 to 2034
Figure 119: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034
Figure 120: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 121: East Asia Market Value (US$ Million) by Prescription Based, 2024 to 2034
Figure 122: East Asia Market Value (US$ Million) by Application, 2024 to 2034
Figure 123: East Asia Market Value (US$ Million) by End User, 2024 to 2034
Figure 124: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 128: East Asia Market Value (US$ Million) Analysis by Prescription Based, 2019 to 2034
Figure 129: East Asia Market Value Share (%) and BPS Analysis by Prescription Based, 2024 to 2034
Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Prescription Based, 2024 to 2034
Figure 131: East Asia Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 134: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 135: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 137: East Asia Market Attractiveness by Prescription Based, 2024 to 2034
Figure 138: East Asia Market Attractiveness by Application, 2024 to 2034
Figure 139: East Asia Market Attractiveness by End User, 2024 to 2034
Figure 140: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 141: Middle East and Africa Market Value (US$ Million) by Prescription Based, 2024 to 2034
Figure 142: Middle East and Africa Market Value (US$ Million) by Application, 2024 to 2034
Figure 143: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034
Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Prescription Based, 2019 to 2034
Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Prescription Based, 2024 to 2034
Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Prescription Based, 2024 to 2034
Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 157: Middle East and Africa Market Attractiveness by Prescription Based, 2024 to 2034
Figure 158: Middle East and Africa Market Attractiveness by Application, 2024 to 2034
Figure 159: Middle East and Africa Market Attractiveness by End User, 2024 to 2034
Figure 160: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
The market is valued at USD 665 million in 2024.
The market is anticipated to be valued at USD 861.3 million by 2034.
In Canada, demand is anticipated to develop at a CAGR of 2.0% through 2034.
The market is projected to register a CAGR of 2.50% from 2024 to 2034.
The contract manufacturing organizations develops demand for ibuprofen APIs with a 55.3% market share in 2024.
Explore Similar Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.